Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids

Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids

The global health emergency for SARS-CoV-2 (COVID-19) created an urgent need to develop new treatments and therapeutic drugs. In this study, we tested, for the first time on human cells, a new tetravalent neutralizing antibody (15033-7) targeting Spike protein and a synthetic peptide homologous to d...

Full description

Bibliographic Details
Main Authors: Paola Spitalieri, Federica Centofanti, Michela Murdocca, Maria Giovanna Scioli, Andrea Latini, Silvia Di Cesare, Gennaro Citro, Antonio Rossi, Augusto Orlandi, Shane Miersch, Sachdev S. Sidhu, Pier Paolo Pandolfi, Annalisa Botta, Federica Sangiuolo, Giuseppe Novelli
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cells
Subjects:
hiPSCs
hLORGs
SARS-CoV2 pseudovirus
neutralizing monoclonal antibody
synthetic peptide
Online Access:https://www.mdpi.com/2073-4409/11/7/1235

Internet

https://www.mdpi.com/2073-4409/11/7/1235

Similar Items